Trek Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
5,945
+418
+8% +$24K 0.02% 386
2026
Q1
$335K Sell
5,527
-481
-8% -$28K 0.02% 358
2025
Q4
$324K Sell
6,008
-26,966
-82% -$1.3M 0.02% 354
2025
Q3
$1.49M Buy
+32,974
New +$1.54M 0.09% 199

Other funds holding BMY

Trek Financial's BMY Position: Q2 2026 in Review

Trek Financial increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q2 2026, buying an estimated $24K and bringing the position to 5,945 shares worth $343K. The position accounts for 0.02% of the portfolio, ranked #386.

Trek Financial first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.49M in Q3 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Trek Financial held 5,945 shares of Bristol-Myers Squibb worth $343K as of Q2 2026.
  • Trek Financial bought 418 Bristol-Myers Squibb shares in Q2 2026, an estimated $24K.
  • Bristol-Myers Squibb made up 0.02% of Trek Financial's portfolio in Q2 2026, its #386 holding.
  • Trek Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • Trek Financial's Bristol-Myers Squibb position peaked at $1.49M in Q3 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.